AbbVie
ABBV
#26
Rank
A$535.53 B
Marketcap
$303.05
Share price
-0.50%
Change (1 day)
39.09%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of June 2024 : A$107.29 Billion

According to AbbVie's latest financial reports the company's total debt is A$107.29 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$87.16 B-6.25%
2022-12-31A$92.97 B-12.1%
2021-12-31A$105.77 B-5.49%
2020-12-31A$111.91 B17.43%
2019-12-31A$95.30 B66.56%
2018-12-31A$57.22 B19.55%
2017-12-31A$47.86 B-6.35%
2016-12-31A$51.11 B17.56%
2015-12-31A$43.47 B137.56%
2014-12-31A$18.30 B10.87%
2013-12-31A$16.50 B9.45%
2012-12-31A$15.08 B32114.79%
2011-12-31A$46.81 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$104.32 B-2.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$78.07 B-27.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$47.27 B-55.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$91.74 B-14.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$35.46 B-66.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.11 B-90.57%๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.64 B-69.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$50.93 B-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$0.38 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA